Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Chloroquine (0.03% w/v) Eye Drops
Therapeutic Category
Ophthalmology, Immunology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
10ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Chlovine Eye Drops contain Chloroquine 0.03% w/v, a specialty ophthalmic formulation used in select inflammatory and immune-related eye conditions as advised by ophthalmologists. Its controlled concentration ensures targeted ocular action with reliable tolerability.
Chloroquine exhibits anti-inflammatory and immunomodulatory properties, helping to reduce ocular inflammation and associated symptoms while supporting improved patient comfort during treatment.
From a commercial standpoint, Chlovine Eye Drops cater to a niche yet valuable ophthalmic segment, making them a distinctive addition for clinics and specialty eye care centers, ensuring prescription-driven, consistent demand.
Including Chlovine Eye Drops in your PCD portfolio strengthens the specialty ophthalmic range, offering portfolio differentiation, prescriber confidence, and long-term business value for pharma franchise partners.
Common side effects may include mild burning or stinging sensation, temporary blurred vision, or eye irritation after application. Rarely, allergic reactions or increased eye discomfort may occur.
Chlovine Eye Drops are indicated for the management of certain superficial ocular infections and inflammatory eye conditions as advised by an ophthalmologist. It may be prescribed in cases where control of infection and inflammation is required.
Use Chlovine Eye Drops strictly under the guidance of an ophthalmologist. Avoid touching the dropper tip to the eye to prevent contamination. Do not use for prolonged periods without medical supervision. Discontinue use and consult a doctor if severe irritation, allergic reaction, or worsening of symptoms occurs.
Store in a cool, dry place below 25 °C. Protect from direct sunlight, keep the bottle tightly closed, and out of reach of children. Do not use after the expiry date.
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Chloroquine 0.03% w/v Eye Drops have niche demand in the ophthalmology and specialty eye care segment, making them a valuable addition for medical distributors, wholesalers, and pharma franchise partners focusing on comprehensive ophthalmic portfolios.
Medical distributors and agencies can benefit from demand in specialized ophthalmic care under the guidance of eye care professionals. Chloroquine 0.03% w/v is used in specific ophthalmic applications as prescribed by ophthalmologists Commonly utilized in the management of selected ocular conditions where anti-inflammatory and therapeutic support is required under specialist supervision Eye drop formulation allows direct application to the affected eye tissues for targeted action Frequently supplied to ophthalmology clinics, eye hospitals, and specialty eye care centers Helps expand a distributor’s portfolio in the ophthalmic specialty segment Prescribed and monitored by qualified ophthalmologists based on individual patient requirements This strengthens a comprehensive ophthalmology and specialty eye care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Chloroquine 0.03% w/v Eye Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from access to a specialized ophthalmic product range, reliable supply chain support, repeat business opportunities from eye care institutions, and attractive margins in the specialty eye care category.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.